The most important problems and needs of rasopathy patients with a noonan syndrome spectrum disorder. 2023

Dagmar K Tiemens, and Lotte Kleimeier, and Erika Leenders, and Ellen Wingbermühle, and Renee L Roelofs, and Barbara Sibbles, and Floor S M Oostwegel, and Eva Vroonland, and Conny van Leeuwen, and Hanneke Niessen, and Paul Sonnega, and Anniek Duursma, and Michel A A P Willemsen, and Jos M T Draaisma, and Carina A C M Pittens
Department of Pediatrics, Radboud Institute for Health Sciences, Amalia Children's Hospital, Radboud university medical center, Nijmegen, The Netherlands.

Noonan syndrome spectrum disorders (NSSDs) constitute a group within the Rasopathies, and are one of the largest groups of syndromes with impact on multi-organ involvement known. The extreme variability of the clinical phenotype is, among others, due to the numerous different genes that are involved, and the differences in clinical presentation over the life span. We have studied the needs of patients and their relatives aiming to develop, evaluate and choose focus in research, medical care and policy to better meet their perspectives. Using the participatory and interactive Dialogue method, 80 patients and relatives mentioned 53 different problems or needs (topics) that were categorized into eight themes. These themes and the topics within each theme, were subsequently prioritized by putting them in order of importance methodologically. The four highest prioritized themes were: (1) Physical problems (non-musculoskeletal related); (2) Social, emotional and behavioral problems; (3) Cognitive functioning and information processing; and (4) Problems related to the musculoskeletal system. Nineteen out of the 53 topics were physical problems. According to the total group of respondents, the top 3 prioritized topics within theme 1 were coagulation problems, heart problems, and feeding problems. Also data stratified by age groups, phenotype (NS and other NSSDs) and gender showed some remarkable results. For instance, feeding problems were prioritized as the most important topic of the highest prioritized theme, according to patients aged 0-12 years. Also feeding problems show a significant difference in its prioritization according to female patients (2) compared to male patients (7). On the other hand, heart problems were not mentioned in the top three prioritized topics in the youngest age groups, although heart problems are generally considered most important for patients with NSSD. With our results we underline the importance of methodologically inventorying the needs of NSSD patients, not only at the group level, but to also focus on specific needs according to e.g. age, phenotype and gender. For instance, it is remarkable that both the current Clinical Guidelines and the Noonan Syndrome diagnostic criteria give little to no attention to feeding problems, though our results indicate that, to the youngest patients, these problems have top priority. A similar situation appears to apply to the clinical management of e.g. coagulation, neuropsychological and musculoskeletal problems (like physiotherapy or occupational therapy) and to a need for (educational) tools to support patients at school or at work. Our study may help to shape targeted (clinical) management, research and policy inside and outside medical (research) institutes and shed light on the complex phenotypes of NSSDs, the families' and patients' perspectives on the everyday consequences of the many different problems, as well as their needs.

UI MeSH Term Description Entries
D008297 Male Males
D009634 Noonan Syndrome A genetically heterogeneous, multifaceted disorder characterized by short stature, webbed neck, ptosis, skeletal malformations, hypertelorism, hormonal imbalance, CRYPTORCHIDISM, multiple cardiac abnormalities (most commonly including PULMONARY VALVE STENOSIS), and some degree of INTELLECTUAL DISABILITY. The phenotype bears similarities to that of TURNER SYNDROME that occurs only in females and has its basis in a 45, X karyotype abnormality. Noonan syndrome occurs in both males and females with a normal karyotype (46,XX and 46,XY). Mutations in a several genes (PTPN11, KRAS, SOS1, NF1 and RAF1) have been associated the NS phenotype. Mutations in PTPN11 are the most common. LEOPARD SYNDROME, a disorder that has clinical features overlapping those of Noonan Syndrome, is also due to mutations in PTPN11. In addition, there is overlap with the syndrome called neurofibromatosis-Noonan syndrome due to mutations in NF1. Male Turner Syndrome,Turner Syndrome, Male,Familial Turner Syndrome,Female Pseudo-Turner Syndrome,Noonan Syndrome 1,Noonan-Ehmke Syndrome,Pseudo-Ullrich-Turner Syndrome,Turner Phenotype with Normal Karyotype,Turner's Phenotype, Karyotype Normal,Turner's Syndrome, Male,Turner-Like Syndrome,Ullrich-Noonan Syndrome,Female Pseudo Turner Syndrome,Male Turner's Syndrome,Noonan Ehmke Syndrome,Pseudo Ullrich Turner Syndrome,Pseudo-Turner Syndrome, Female,Turner Like Syndrome,Turner Syndrome, Familial,Ullrich Noonan Syndrome
D010641 Phenotype The outward appearance of the individual. It is the product of interactions between genes, and between the GENOTYPE and the environment. Phenotypes
D003071 Cognition Intellectual or mental process whereby an organism obtains knowledge. Cognitive Function,Cognitions,Cognitive Functions,Function, Cognitive,Functions, Cognitive
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

Dagmar K Tiemens, and Lotte Kleimeier, and Erika Leenders, and Ellen Wingbermühle, and Renee L Roelofs, and Barbara Sibbles, and Floor S M Oostwegel, and Eva Vroonland, and Conny van Leeuwen, and Hanneke Niessen, and Paul Sonnega, and Anniek Duursma, and Michel A A P Willemsen, and Jos M T Draaisma, and Carina A C M Pittens
March 2022, BMJ case reports,
Dagmar K Tiemens, and Lotte Kleimeier, and Erika Leenders, and Ellen Wingbermühle, and Renee L Roelofs, and Barbara Sibbles, and Floor S M Oostwegel, and Eva Vroonland, and Conny van Leeuwen, and Hanneke Niessen, and Paul Sonnega, and Anniek Duursma, and Michel A A P Willemsen, and Jos M T Draaisma, and Carina A C M Pittens
April 2020, Molecular genetics & genomic medicine,
Dagmar K Tiemens, and Lotte Kleimeier, and Erika Leenders, and Ellen Wingbermühle, and Renee L Roelofs, and Barbara Sibbles, and Floor S M Oostwegel, and Eva Vroonland, and Conny van Leeuwen, and Hanneke Niessen, and Paul Sonnega, and Anniek Duursma, and Michel A A P Willemsen, and Jos M T Draaisma, and Carina A C M Pittens
December 2025, American journal of hematology,
Dagmar K Tiemens, and Lotte Kleimeier, and Erika Leenders, and Ellen Wingbermühle, and Renee L Roelofs, and Barbara Sibbles, and Floor S M Oostwegel, and Eva Vroonland, and Conny van Leeuwen, and Hanneke Niessen, and Paul Sonnega, and Anniek Duursma, and Michel A A P Willemsen, and Jos M T Draaisma, and Carina A C M Pittens
May 2025, Head and neck pathology,
Dagmar K Tiemens, and Lotte Kleimeier, and Erika Leenders, and Ellen Wingbermühle, and Renee L Roelofs, and Barbara Sibbles, and Floor S M Oostwegel, and Eva Vroonland, and Conny van Leeuwen, and Hanneke Niessen, and Paul Sonnega, and Anniek Duursma, and Michel A A P Willemsen, and Jos M T Draaisma, and Carina A C M Pittens
January 1983, Przeglad dermatologiczny,
Dagmar K Tiemens, and Lotte Kleimeier, and Erika Leenders, and Ellen Wingbermühle, and Renee L Roelofs, and Barbara Sibbles, and Floor S M Oostwegel, and Eva Vroonland, and Conny van Leeuwen, and Hanneke Niessen, and Paul Sonnega, and Anniek Duursma, and Michel A A P Willemsen, and Jos M T Draaisma, and Carina A C M Pittens
October 2025, Molecular autism,
Dagmar K Tiemens, and Lotte Kleimeier, and Erika Leenders, and Ellen Wingbermühle, and Renee L Roelofs, and Barbara Sibbles, and Floor S M Oostwegel, and Eva Vroonland, and Conny van Leeuwen, and Hanneke Niessen, and Paul Sonnega, and Anniek Duursma, and Michel A A P Willemsen, and Jos M T Draaisma, and Carina A C M Pittens
January 2022, Journal of clinical medicine,
Dagmar K Tiemens, and Lotte Kleimeier, and Erika Leenders, and Ellen Wingbermühle, and Renee L Roelofs, and Barbara Sibbles, and Floor S M Oostwegel, and Eva Vroonland, and Conny van Leeuwen, and Hanneke Niessen, and Paul Sonnega, and Anniek Duursma, and Michel A A P Willemsen, and Jos M T Draaisma, and Carina A C M Pittens
November 2019, Congenital anomalies,
Dagmar K Tiemens, and Lotte Kleimeier, and Erika Leenders, and Ellen Wingbermühle, and Renee L Roelofs, and Barbara Sibbles, and Floor S M Oostwegel, and Eva Vroonland, and Conny van Leeuwen, and Hanneke Niessen, and Paul Sonnega, and Anniek Duursma, and Michel A A P Willemsen, and Jos M T Draaisma, and Carina A C M Pittens
October 2025, American journal of medical genetics. Part A,
Dagmar K Tiemens, and Lotte Kleimeier, and Erika Leenders, and Ellen Wingbermühle, and Renee L Roelofs, and Barbara Sibbles, and Floor S M Oostwegel, and Eva Vroonland, and Conny van Leeuwen, and Hanneke Niessen, and Paul Sonnega, and Anniek Duursma, and Michel A A P Willemsen, and Jos M T Draaisma, and Carina A C M Pittens
June 1997, The Journal of pediatrics,
Copied contents to your clipboard!